GlassScriptPhysician profile
Anne Rowland
NPI 1689840571
$2,800.60
in general payments reported to CMS, 2019-2025
24 companies · $691 in 2025
The $691 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $893 · 2022: $145 · 2023: $480 · 2024: $592 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,762.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $821.65 | 2021-2025 | Airsupra, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $540.82 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.12 | 2021-2024 | Ofev |
| Electromed, INC. | $113.51 | 2021-2025 | Smartvest |
| Axsome Therapeutics, INC. | $98.40 | 2024-2025 | Sunosi |
| Inspire Medical Systems, INC. | $97.56 | 2023-2024 | Inspire |
| Teva Pharmaceuticals USA, INC. | $95.23 | 2021 | |
| Grifols USA, LLC | $87.61 | 2023-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $77.53 | 2021 | |
| Viatris Specialty LLC | $76.40 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $73.50 | 2021-2024 | Glassia |
| United Therapeutics Corporation | $68.81 | 2024-2025 | Tyvaso, Tyvaso |
| Actelion Pharmaceuticals US, INC. | $67.50 | 2021-2025 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $62.87 | 2021-2024 | Yupelri |
| Genzyme Corporation | $55.97 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $49.00 | 2021-2024 | Acthar |
| Baxter Healthcare | $36.91 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Amgen INC. | $36.48 | 2024 | Tezspire |
| Gilead Sciences, INC. | $26.12 | 2021 | |
| Novo Nordisk INC | $18.51 | 2025 | Wegovy |
| Insmed, INC. | $16.95 | 2025 | Brinsupri, Arikayce |
| Philips North America LLC | $15.90 | 2021 | |
| Astellas Pharma US INC | $14.75 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Rowland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.